APIMEDS PHARMACEUTICALS US Stock Price, News & Analysis
APUS
NYSE
Company Description
Welcome to the overview page for APIMEDS PHARMACEUTICALS US (APUS), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
$�
0.00%
0.00
Last updated:
-17.73 %
Performance 1 year
$25.5M
Market Cap
11.6M
Shares outstanding
Latest News
SEC Filings
Financial Highlights
$0
Revenue (TTM)
-$2,662,193
Net Income (TTM)
-$0.26
Diluted EPS (TTM)
-$3,361,096
Operating Cash Flow
12.79
Current Ratio
-$2,663,904
Operating Income
Upcoming Events
Frequently Asked Questions
What is the current stock price of APIMEDS PHARMACEUTICALS US (APUS)?
The current stock price of APIMEDS PHARMACEUTICALS US (APUS) is $1.935 as of August 25, 2025.
What is the market cap of APIMEDS PHARMACEUTICALS US (APUS)?
The market cap of APIMEDS PHARMACEUTICALS US (APUS) is approximately 25.5M.
What is the revenue (TTM) of APIMEDS PHARMACEUTICALS US (APUS) stock?
The trailing twelve months (TTM) revenue of APIMEDS PHARMACEUTICALS US (APUS) is $0.
What is the net income of APIMEDS PHARMACEUTICALS US (APUS)?
The trailing twelve months (TTM) net income of APIMEDS PHARMACEUTICALS US (APUS) is -$2,662,193.
What is the earnings per share (EPS) of APIMEDS PHARMACEUTICALS US (APUS)?
The diluted earnings per share (EPS) of APIMEDS PHARMACEUTICALS US (APUS) is -$0.26 on a trailing twelve months (TTM) basis.
What is the operating cash flow of APIMEDS PHARMACEUTICALS US (APUS)?
The operating cash flow of APIMEDS PHARMACEUTICALS US (APUS) is -$3,361,096.
What is the current ratio of APIMEDS PHARMACEUTICALS US (APUS)?
The current ratio of APIMEDS PHARMACEUTICALS US (APUS) is 12.79, indicating the company's ability to pay short-term obligations.
What is the operating income of APIMEDS PHARMACEUTICALS US (APUS)?
The operating income of APIMEDS PHARMACEUTICALS US (APUS) is -$2,663,904.